Canlyniadau Chwilio - Jan Steffel

Mireinio'r Canlyniadau
  1. 1
    Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolism

    Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolism gan Jan Steffel, Eugene Braunwald

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Superresponse to Cardiac Resynchronization Therapy

    Superresponse to Cardiac Resynchronization Therapy gan Jan Steffel, Frank Ruschitzka

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Sweet and Sour

    Sweet and Sour gan Thomas F. Lüscher, Jan Steffel

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Carta
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Tissue Factor in Cardiovascular Diseases

    Tissue Factor in Cardiovascular Diseases gan Jan Steffel, Thomas F. Lüscher, Felix C. Tanner

    Cyhoeddwyd 2006
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Electrocardiographic Characteristics at Initial Diagnosis in Patients With Isolated Left Ventricular Noncompaction

    Electrocardiographic Characteristics at Initial Diagnosis in Patients With Isolated Left Ventricular Noncompaction gan Jan Steffel, Richard Kobza, Erwin Oechslin, Rolf Jenni, Fırat Duru

    Cyhoeddwyd 2009
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Histamine Induces Tissue Factor Expression

    Histamine Induces Tissue Factor Expression gan Jan Steffel, Alexander Akhmedov, Helen Greutert, Thomas F. Lüscher, Felix C. Tanner

    Cyhoeddwyd 2005
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Leadless pacemaker implantation via the internal jugular vein

    Leadless pacemaker implantation via the internal jugular vein gan Nadine Molitor, Shmaila Saleem‐Talib, Hemanth Ramanna, Daniel Höfer, Alexander Breitenstein, Jan Steffel

    Cyhoeddwyd 2024
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy

    Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy gan S. Schmidt, David Hürlimann, Christoph Starck, G Hindricks, Thomas F. Lüscher, Frank Ruschitzka, Jan Steffel

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage

    Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage gan Christoph Starck, Jan Steffel, Maximilian Y. Emmert, André Plass, S. Mahapatra, Volkmar Falk, Sacha P. Salzberg

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    The COMPASS Trial

    The COMPASS Trial gan Jan Steffel, John W. Eikelboom, Sonia S. Anand, Olga Shestakovska, Salim Yusuf, Keith A.A. Fox

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Celecoxib Decreases Endothelial Tissue Factor Expression Through Inhibition of c-Jun Terminal NH <sub>2</sub> Kinase Phosphorylation

    Celecoxib Decreases Endothelial Tissue Factor Expression Through Inhibition of c-Jun Terminal NH <sub>2</sub> Kinase Phosphorylation gan Jan Steffel, Matthias Hermann, Helen Greutert, Steffen Gay, Thomas F. Lüscher, Frank Ruschitzka, Felix C. Tanner

    Cyhoeddwyd 2005
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Rapamycin, but Not FK-506, Increases Endothelial Tissue Factor Expression

    Rapamycin, but Not FK-506, Increases Endothelial Tissue Factor Expression gan Jan Steffel, Roberto Adriano Latini, Alexander Akhmedov, Dorothee Zimmermann, Pamela Zimmerling, Thomas F. Lüscher, Felix C. Tanner

    Cyhoeddwyd 2005
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Drug-Eluting Stent and Coronary Thrombosis

    Drug-Eluting Stent and Coronary Thrombosis gan Thomas F. Lüscher, Jan Steffel, Franz R. Eberli, Michael Joner, Gaku Nakazawa, Felix C. Tanner, Renu Virmani

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    The effects of continuous positive airway pressure therapy withdrawal on cardiac repolarization: data from a randomized controlled trial

    The effects of continuous positive airway pressure therapy withdrawal on cardiac repolarization: data from a randomized controlled trial gan Valentina A. Rossi, Anne‐Christin Stoewhas, Giovanni Camen, Jan Steffel, Konrad E. Bloch, John Stradling, Marianne Køhler

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling

    Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling gan Georg Fröhlich, Jan Steffel, David Hürlimann, Frank Enseleit, Thomas F. Lüscher, Frank Ruschitzka, William T. Abraham, Johannes Holzmeister

    Cyhoeddwyd 2010
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents

    Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents gan Giovanni G. Camici, Jan Steffel, I. Amanovic, Alexander Breitenstein, Jeannette Baldinger, Stephan Sylvest Keller, Thomas F. Lüscher, Felix C. Tanner

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review

    Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systemati... gan Neal A. Chatterjee, Attila Róka, Steven A. Lubitz, Michael R. Gold, Claude Daubert, Cecilia Linde, Jan Steffel, G. André Ng, Theofanie Mela

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial

    Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial gan Jan Steffel, Robert P. Giugliano, Eugene Braunwald, Sabina A. Murphy, Dan Atar, Hein Heidbüchel, A. John Camm, Elliott M. Antman, Christian T. Ruff

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation

    Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation gan Jan Steffel, Christian T. Ruff, Ophelia Yin, Eugene Braunwald, Jeong‐Gun Park, Sabina A. Murphy, Stuart J. Connolly, Elliott M. Antman, Robert P. Giugliano

    Cyhoeddwyd 2021
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling

    Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling gan Jan Steffel, Robert P. Giugliano, Eugene Braunwald, Sabina A. Murphy, Michele Mercuri, Youngsook Choi, Philip E. Aylward, Harvey D. White, Josè Luis Zamorano, Elliott M. Antman, Christian T. Ruff

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: